ZIMMER BIOMET HOLDINGS, INC. - Common Stock (ZBH)
CUSIP: 98956P102
Q4 2021 13F Holders as of 31 Dec 2021
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 197,817,790
- Total 13F shares
- 186,413,133
- Share change
- -1,548,568
- Total reported value
- $23,689,681,090
- Put/Call ratio
- 87%
- Price per share
- $127.04
- Number of holders
- 970
- Value change
- -$291,970,620
- Number of buys
- 389
- Number of sells
- 439
Quarterly Holders Quick Answers
What is CUSIP 98956P102?
CUSIP 98956P102 identifies ZBH - ZIMMER BIOMET HOLDINGS, INC. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 98956P102:
Top shareholders of ZBH - ZIMMER BIOMET HOLDINGS, INC. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| BlackRock Finance, Inc. |
13F
|
Company |
11%
|
21,565,511
|
$3,156,329,000 | — | 30 Sep 2021 | |
| VANGUARD GROUP INC |
13F
|
Company |
8.2%
|
16,152,995
|
$2,364,152,000 | — | 30 Sep 2021 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
5.8%
|
11,532,141
|
$1,687,845,000 | — | 30 Sep 2021 | |
| STATE STREET CORP |
13F
|
Company |
4.4%
|
8,738,617
|
$1,281,073,000 | — | 30 Sep 2021 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
3.9%
|
7,771,441
|
$1,137,428,000 | — | 30 Sep 2021 | |
| Capital Research Global Investors |
13F
|
Company |
3.1%
|
6,061,083
|
$887,127,000 | — | 30 Sep 2021 | |
| AMERICAN CENTURY COMPANIES INC |
13F
|
Company |
2.2%
|
4,259,604
|
$623,436,000 | — | 30 Sep 2021 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
2.1%
|
4,058,585
|
$594,014,000 | — | 30 Sep 2021 | |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ |
13F
|
Company |
2%
|
3,941,248
|
$576,841,000 | — | 30 Sep 2021 | |
| Capital International Investors |
13F
|
Company |
2%
|
3,911,932
|
$572,550,000 | — | 30 Sep 2021 | |
| PRIMECAP MANAGEMENT CO/CA/ |
13F
|
Company |
2%
|
3,877,910
|
$567,571,000 | — | 30 Sep 2021 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.9%
|
3,708,563
|
$541,344,000 | — | 30 Sep 2021 | |
| VIKING GLOBAL INVESTORS LP |
13F
|
Company |
1.7%
|
3,409,073
|
$498,952,000 | — | 30 Sep 2021 | |
| Bank of New York Mellon Corp |
13F
|
Company |
1.6%
|
3,206,698
|
$469,331,000 | — | 30 Sep 2021 | |
| NORDEA INVESTMENT MANAGEMENT AB |
13F
|
Company |
1.4%
|
2,817,577
|
$422,130,000 | — | 30 Sep 2021 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
1.4%
|
2,739,611
|
$400,969,000 | — | 30 Sep 2021 | |
| Amundi |
13F
|
Individual |
1.3%
|
2,600,874
|
$380,665,000 | — | 30 Sep 2021 | |
| NORTHERN TRUST CORP |
13F
|
Company |
1.3%
|
2,578,479
|
$377,386,000 | — | 30 Sep 2021 | |
| Boston Partners |
13F
|
Company |
1.2%
|
2,434,429
|
$356,313,000 | — | 30 Sep 2021 | |
| Longview Partners (Guernsey) LTD |
13F
|
Company |
1.2%
|
2,426,348
|
$355,120,000 | — | 30 Sep 2021 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
1.2%
|
2,311,427
|
$338,299,000 | — | 30 Sep 2021 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
1.1%
|
2,267,109
|
$331,814,000 | — | 30 Sep 2021 | |
| Invesco Ltd. |
13F
|
Company |
1%
|
2,069,639
|
$302,911,000 | — | 30 Sep 2021 | |
| MACQUARIE GROUP LTD |
13F
|
Company |
1%
|
2,012,767
|
$294,588,000 | — | 30 Sep 2021 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
1%
|
1,990,839
|
$291,379,000 | — | 30 Sep 2021 | |
| NORGES BANK |
13F
|
Company |
0.96%
|
1,905,128
|
$278,835,000 | — | 30 Sep 2021 | |
| Legal & General Group Plc |
13F
|
Company |
0.83%
|
1,635,665
|
$239,397,000 | — | 30 Sep 2021 | |
| NUANCE INVESTMENTS, LLC |
13F
|
Company |
0.65%
|
1,295,638
|
$189,630,000 | — | 30 Sep 2021 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.65%
|
1,280,778
|
$187,455,000 | — | 30 Sep 2021 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.61%
|
1,208,573
|
$176,924,000 | — | 30 Sep 2021 | |
| VAN ECK ASSOCIATES CORP |
13F
|
Company |
0.6%
|
1,184,335
|
$173,339,000 | — | 30 Sep 2021 | |
| Ceredex Value Advisors LLC |
13F
|
Company |
0.57%
|
1,122,383
|
$164,540,000 | — | 30 Sep 2021 | |
| JENNISON ASSOCIATES LLC |
13F
|
Company |
0.57%
|
1,123,034
|
$164,367,000 | — | 30 Sep 2021 | |
| HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.54%
|
1,059,698
|
$155,097,000 | — | 30 Sep 2021 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.48%
|
954,571
|
$139,711,000 | — | 30 Sep 2021 | |
| MORGAN STANLEY |
13F
|
Company |
0.47%
|
925,822
|
$135,503,000 | — | 30 Sep 2021 | |
| Third Point LLC |
13F
|
Company |
0.45%
|
900,000
|
$131,724,000 | — | 30 Sep 2021 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
0.43%
|
848,788
|
$124,232,000 | — | 30 Sep 2021 | |
| FMR LLC |
13F
|
Company |
0.42%
|
835,194
|
$122,238,000 | — | 30 Sep 2021 | |
| Swiss National Bank |
13F
|
Company |
0.42%
|
824,765
|
$120,713,000 | — | 30 Sep 2021 | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC |
13F
|
Company |
0.39%
|
764,183
|
$111,845,822 | — | 30 Sep 2021 | |
| Camber Capital Management LP |
13F
|
Company |
0.37%
|
725,090
|
$106,124,000 | — | 30 Sep 2021 | |
| PARAMETRIC PORTFOLIO ASSOCIATES LLC |
13F
|
Company |
0.36%
|
709,809
|
$103,888,000 | — | 30 Sep 2021 | |
| Neuberger Berman Group LLC |
13F
|
Company |
0.35%
|
693,172
|
$101,262,000 | — | 30 Sep 2021 | |
| JOHNSON INVESTMENT COUNSEL INC |
13F
|
Company |
0.35%
|
683,121
|
$100,145,000 | — | 30 Sep 2021 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
0.35%
|
683,502
|
$100,038,000 | — | 30 Sep 2021 | |
| ORBIMED ADVISORS LLC |
13F
|
Company |
0.33%
|
660,800
|
$96,715,000 | — | 30 Sep 2021 | |
| BARCLAYS PLC |
13F
|
Company |
0.32%
|
628,886
|
$92,044,000 | — | 30 Sep 2021 | |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP |
13F
|
Company |
0.31%
|
608,954
|
$89,127,000 | — | 30 Sep 2021 | |
| Focused Investors LLC |
13F
|
Company |
0.31%
|
604,500
|
$88,475,000 | — | 30 Sep 2021 |
Institutional Holders of ZIMMER BIOMET HOLDINGS, INC. - Common Stock (ZBH) as of Q4 2021
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2021 vs Q3 2021 Across Filers
| Investor | Q3 2021 Shares | Q4 2021 Shares | Share Diff | Share Chg % | Q3 2021 Value $ | Q4 2021 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
An asterisk sign (*) next to the price indicates that the price is likely invalid.